Search results
Kim Kardashian’s Met Gala Look Had 1 Detail So Extreme It Made People Uncomfortable
HuffPost· 19 hours agoKim Kardashian courted controversy at Monday’s Met Gala due to a very uncomfortable-looking aspect...
Malaga Cove Capital LLC Acquires New Shares in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 8 hours agoMalaga Cove Capital LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the ...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 5 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 21 hours agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 6 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
13 Times Met Gala Attendees Took "Beauty Is Pain" Way Too Seriously And Wore Looks That Physically...
BuzzFeed via Yahoo News· 4 days agoFor Kim Kardashian, wearing her famous Mugler "wet look" dress was one of the most painful...
MoonLake Immunotherapeutics Reports Q1 2024 Financial Outcomes
GuruFocus.com via Yahoo Finance· 16 hours agoThe company's leading investigational product, sonelokimab, targets IL-17A and IL-17F, which are key drivers of inflammation in conditions such as hidradenitis suppurativa (HS) and ...
Consolidated Planning Corp Sells 1,063 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoConsolidated Planning Corp lessened its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 29,072 shares of ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 5 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...